« Selective JAK1 Inhibition Using Upadacitinib for the Management of Inflammatory Bowel Diseases: The Powerful Pill ». Canadian IBD Today 1, no. S11 (novembre 23, 2023): 2–11. Consulté le mars 31, 2026. https://canadianibdtoday.com/article/view/1-s11-narula_hamam.